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Background: Circular RNAs (circRNAs) are known to participate in lung cancer. However, their role 
in spinal metastasis (SM) of lung adenocarcinoma remains elusive. In this study, we determined that hsa_
circ_0006571 serves as a sponge for miR-138, which targets sirtuin 1 (Sirt1) in the development of SM.
Methods: A human circRNA microarray was performed to compare SM and lung adenocarcinoma samples. 
The expression of hsa_circ_0006571 and miR-138 was determined using quantitative polymerase chain 
reaction (qPCR) in vitro and in vivo. Cell proliferation was performed by Cell Counting Kit-8 (CCK-8) and 
apoptosis was analyzed by Annexin V/PI staining. RNA-pulldown and RNA immunoprecipitation (RIP) 
were used to analyze the interaction between hsa_circ_0006571. Tumor metastasis was determined through a 
xenograft experiment in vivo.
Results: Hsa_circ_0006571 was observed to be significantly upregulated in SM tissues through circRNA 
microarray and qPCR. We detected a lower expression of miR-138 in SM tissues compared with lung 
adenocarcinoma. Hsa_circ_0006571 silencing suppressed lung cancer cell proliferation and migration while 
promoting apoptosis. Hsa_circ_0006571 interacted with miR-138 to promote expression of Sirt1, leading to 
activation of epithelial-mesenchymal transition (EMT). Xenograft experiments showed that downregulation 
of hsa_circ_0006571 delayed the SM of lung adenocarcinoma cells via the miR-138-Sirt1 axis.
Conclusions: Hsa_circ_0006571 promoted tumor cell migration and invasion via the miR-138/Sirt1 
pathway. Our observations indicate that circRNAs are possible novel therapeutic targets for SM of lung 
adenocarcinoma.
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Introduction
Lung carcinoma is the primary cause of cancer-related 
mortality worldwide, accounting for almost 20% of all 
deaths caused by tumors (1,2). More than 65% of patients 
with lung carcinoma have local or disseminated metastatic 
disease at diagnosis (3,4). Tumor cells can metastasize 
locally to the lymph nodes and distant organs, including 
bone. The spine is the most common site of bone metastasis 
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in lung cancer, with 42% of patients with bone metastasis 
developing spinal metastasis (SM), followed by the ribs 
(27%); however, metastasis rarely occurs in appendicular 
bones (<6%) (5,6). SM is viewed as a deleterious stage 
which results in a series of skeletal-associated adverse 
events, especially paraplegia and lifelong urinary and fecal 
incontinence.
In recent years, studies have increasingly verified that 
aberrant gene expression due to genomic instability or 
alteration of epigenetic markers can play a major role 
in lung cancer metastasis (7,8). As with most malignant 
tumors, lung cancer metastasis is usually associated with a 
specific genetic chromosome abnormality (9). 
Circular RNAs (circRNAs) and microRNAs (miRNAs) 
are non-coding RNAs (ncRNAs) that have been studied 
within cancer context in recent years (10,11). CircRNA 
are highly stable ncRNAs generated by non-canonical 
splicing of pre-mRNAs (12). CircRNAs can act as miRNA 
sponges regulating the function of miRNAs in health and 
disease (13). For instance, circC3P1 inhibits liver cancer 
progression through the miR-4641/PCK1 signaling 
pathway (14). Some researchers have demonstrated that 
circMAN2B2 regulates the miR-1275/FOXK1 pathway, 
thereby inducing the progression of lung cancer (15). 
MiRNAs are important non-coding RNAs that exert 
their post-transcriptional regulatory effects by regulating 
protein-coding gene transcripts (16). Through targeting 
multiple mRNA transcripts, miRNAs can regulate a variety 
of biological processes, including migration, apoptosis, and 
cell proliferation. Notably, the deregulation of miRNA 
expression through the sponge function of circRNAs may 
be crucial in cancer etiology (17).
In our study, we discovered lower expression of tumor 
suppressor miR-138 in SM tissues compared with lung 
adenocarcinoma, and verified the results using lung cancer 
cell lines. H1975 and SPA-1 cells migration and invasion 
was inhibited by the overexpression of miR-138 in vitro. 
By microarray analysis, we revealed that hsa_circ_0006571, 
generated from the back-splicing of special AT-rich 
sequence binding protein 2 (SATB2) gene transcript, was 
significantly upregulated in SM tissues. Furthermore, 
we demonstrated that hsa_circ_0006571 could inhibit 
proliferation and metastatic progression of lung cancer cells 
via binding to miR-138 as a miRNA sponge to regulate 
sirtuin 1 (Sirt1) expression. Therefore, hsa_circ_0006571 
may have a potential therapeutic effect on lung cancer 
patients. 
We present the following article in accordance with the 
ARRIVE reporting checklist (available at http://dx.doi.
org/10.21037/tlcr-20-1250).
Methods
Patients and tissue samples
Twenty-five cancer lung adenocarcinoma tissues and SM 
tissues were obtained from the Department of Surgery, 
Zhongshan Hospital affiliated to Fudan University. Five 
pairs of samples (lung adenocarcinoma tumor tissues and 
SM tissues) were used for circRNA microarray, and 20 pairs 
were used for RT-quantitative polymerase chain reaction 
(qPCR) validation. All tumor tissues were snap-frozen in 
liquid nitrogen promptly after surgical excision and were 
immediately transferred to a −80 ℃ freezer. The diagnosis 
of lung adenocarcinoma and SM was pathologically 
confirmed. None of the patients in our study had received 
radiotherapy or chemotherapy, or any other cancer therapy 
before surgery. The study was approved by the Ethics 
Committee of Zhongshan Hospital, and written informed 
consent was obtained from all patients. All procedures 
performed in this study involving human participants were 
in accordance with the Declaration of Helsinki (as revised 
in 2013).
Expression profile analysis of circRNAs
The microarray “SBC Human ceRNA microarray v1.0” 
(Biotechnology Corporation, Shanghai, China) was 
used, which detected 88,371 circRNAs. RNA samples 
from each group were then used to generate biotinylated 
cRNA targets for the SBC human ceRNA array V1.0. 
Biotinylated cRNA targets were then hybridized to the 
slides. After hybridization, slides were scanned with an 
Agilent Microarray Scanner (Agilent Technologies, Santa 
Clara, CA, USA). Microarray experiments were performed 
by an Agilent Technologies Inc. protocol at Shanghai 
Biotechnology Corporation. 
Cell culture
Human lung adenocarcinoma cell lines, H1975, A549, 
H1395, and SPC-A1, and a control human bronchial 
epithelial (HBE) cell line were obtained from the Chinese 
Academy of Sciences (Shanghai, China). They were 
cultured in Dulbecco’s Modified Eagle Medium (DMEM) 
with 10% fetal bovine serum (FBS; Gibco, USA) at 37 ℃ 
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with 5% CO2.
RNA oligoribonucleotides and cell transfection
Lentiviral vectors for small hairpin RNAs targeting hsa_
circ_0006571 were produced by Hanyin, China. H1975 cells 
were transfected with the corresponding lentiviruses with 8 
µg/mL polybrene. Puromycin (4 µg/mL) was introduced to 
select H1975 cells with stable hsa_circ_0006571 knockdown 
after 24 h. siRNAs targeting the hsa_circ_0006571 splice 
junction, Sirt1 mRNA, and miR-138 mimic, miR-138 
inhibitor, and their respective controls were synthesized by 
RiboBio (Guangzhou, China). The siRNA sequences were 
listed in Table S1.
RNA immunoprecipitation (RIP) and RNA pull-down
Briefly, an RIP assay using SPC-A1 cells was performed with 
a Magna RIP RNA-Binding Protein Immunoprecipitation 
Kit (Millipore, Billerica, MA, USA). Cells were transfected 
with Flag-Ago2 lentivirus (Genechem, Shanghai, China) 
and then treated with Radio Immunoprecipitation Assay 
(RIPA) Lysis Buffer. The cell lysates were incubated with 
antibodies against Ago2 (Millipore) or normal mouse 
immunoglobulin G (Millipore). After being treated with 
buffer, the immunoprecipitated RNAs were extracted 
from the cell lysates, and western blotting and quantitative 
reverse transcription-polymerase chain reaction (qRT-PCR) 
analysis were then performed. 
An RNA pull-down assay was conducted to verify the 
relationship between hsa_circ_0006571 and miR-138 
using the Pierce Magnetic RNA-Protein Pull-Down Kit 
(BersinBio, Guangzhou, China). For RNA pull-down, 
specific probes were used to hybridize hsa_circ_0006571, 
which was pulled down and identified through qRT-
PCR. SPC-A1 cells were washed with phosphate-buffered 
saline (PBS) and lysed with buffer. A biotinylated antisense 
probe and a control probe were added to the pull-down 
system before the probes were denatured and hybridized. 
Non-specifically bound RNA was removed and miRNAs 
specifically interacting with circRNAs were recovered using 
Trizol reagent. After reverse transcription, qRT-PCR was 
performed to testify binding strength.
Cell Counting Kit-8 (CCK-8) assays
Cells were transfected with siRNA, miR-138 mimic, 
miR-138 inhibitor, and si-hsa_circ_000657 and CCK-
8 (Beyotime, China) to test cell viability. After 2 h of 
incubation, the density values were measured at 450 nm.
Transwell migration assays
Transwell  migration assays were performed using 
Matrigel invasion chambers (8 µm size, Corning, NY, 
USA) following the manufacturer’s instructions. A total 
of 3×104 H1975 and SPA-1 cells were resuspended in 200 
µL serum-free DMEM, and then seeded into the upper 
chambers of Transwell plates, respectively. Complete 
DMEM medium with 5% FBS was placed into the lower 
chamber. Cells adhering to the membrane were fixed in 
4% paraformaldehyde for 15 minutes, stained with crystal 
violet, and counted under a microscope.
Cell cycle assays
After transfection and culture, A total of 3×105 H1975 and 
SPCA-1 cells were harvested and suspended in 500 µL 
of binding buffer, respectively. Then, 5 µL of Annexin 
V-Fluorescein Isothiocyanate/propidium iodide (V-FITC/PI) 
(Beyotime, Shanghai, China) was added to the cell 
suspension, and the cells were incubated at 37 ℃ for 20 min 
in the dark. Flow cytometry analysis (BD-FACS Calibur, 
Franklin Lakes, NJ, USA) was performed to detect cell 
apoptosis and the cell cycle. 
Cell apoptosis assay
A total of 105 A549 and SPC-A1 cells were washed with PBS 
and fixed in 4% paraformaldehyde for 20 minutes. The cells 
were then incubated with 5 µL Annexin V-phycoerythrin 
conjugate and 5 µL propidium iodide (Beyotiome, 
Shanghai, China) for 20 minutes at 37 ℃ in the dark. The 
results were analyzed using FlowJo software (version 10.0) 
(FlowJo, Ashland, OR, USA).
qRT-PCR analysis
The reverse transcription and quantification of miR-138 
were performed with a miRNA qRT-PCR Kit (Tiangen 
Biotech, Beijing, China). RNA was reverse transcribed 
into cDNA using the PrimeScript RT reagent Kit (Takara, 
Japan). An ABI Prism 7500 RealTime PCR system (Applied 
Biosystems, Foster City, USA) was used to carry out qPCR 
using SYBR Premix Ex Taq II (TaKaRa). The 2−ΔΔCt method 
was used to determine the relative gene expression level. 
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The primers are shown in Table S2.
Luciferase reporter assays
The wild-type (WT) sequences with putative hsa-mir-138 
binding site in the three prime untranslated region (3'-UTR) 
of Sirt1 and its mutant dual-luciferase reporter vectors were 
constructed by Hanyin, China. Briefly, the 3'-UTR of the 
human Sirt1 gene was amplified through PCR using the 
following primer sequence: forward primer: 5'-AACGAGC
TCGCTAGCCTCGAGTGTAATAATTGTGCAGGTA
CAGGAATTG-3'; reverse primer: 5'-ATGTCTGCTCG
AAGCGGCCGCGTTAGCTGCCACAGTTTTGGAAA
ATGC-3'. The PCR product was cloned into the multiple 
cloning site of the basic dual-luciferase reporter vector 
pmiGLO, which is located downstream of the luciferase 
reporter gene, between the XhoI and NotI sites, to generate 
pmirGLO-Sirt1-WT. The mutant vector was amplified 
using the following primers: forward primer-1: 5'-TTGTG
CAGGTACAGGAATTGTTCTCATGTTATTAGGAA
CTTTAGCATGTC-3'; reverse primer-1: 5'-ATGTCTG
CTCGAAGCGGCCGCGTTAGCTGCCACAGTTTT
GGAAAATGC-3'; forward primer-2: 5'-AACGAGCTCG
CTAGCCTCGAGTGTAATAATTGTGCAGGTACAG
GAATTG-3'; reverse primer-2: 5'-ATGTCTGCTCGAA
GCGGCCGCGTTAGCTGCCACAGTTTTGGAAAAT
GC-3'. The PCR product was inserted into the pmirGLO 
basic vector.
RNA fluorescence in situ hybridization
The RNA fluorescence in situ hybridization (FISH) assay 
was performed with a Fluorescent In Situ Hybridization Kit 
(RiboBio, China). Cy3-labeled hsa_circ_0006571 probes 
were used to measure with the kit, and then visualized with 
confocal microscopy.
Cell morphology 
H1975 and SPC-A1 cells were planted in a 12-well 
palate and then transfected with si-hsa_circ_000657. The 
cells were cultured for 48 h to allow enough time for 
morphology changes. After 48 h, the plates were washed 
with PBS to remove dead cells. Finally, H1975 and SPC-A1 
cells were observed using an optical microscope (Olympus 
Corporation, Tokyo, Japan), and changes in cell morphology 
were analyzed. When H1975 and SPC-A1 cells show less 
fibroblast-like morphology and cellular protrusions, it 
indicates that epithelial-mesenchymal transition (EMT) 
metastasis is inhibited.
Western blotting
A quantitative protein from tissues and cells (20 µg) was 
injected into Bis-Tris sodium dodecyl sulfate polyacrylamide 
gel electrophoresis (SDS/PAGE) gel and transferred to 
polyvinylidene difluoride (PVDF) membranes. After 
blocking for 1 h at 37 ℃, the membranes were incubated 
overnight at 4 ℃ with the following primary antibodies 
(CST, Danvers, MA, USA): Sirt1 (1:1,000), Vimentin 
(1:1,000), E-cadherin (1:1,000), zonula occludens-1 (ZO-
1) (1:1,000), Snail (1:1,000), zinc finger E-box binding 
homeobox 1 (ZEB1) (1:1,000); cleaved caspase-3 (1:1,000) 
(Beyotime, Shanghai, China); and β-actin antibody (1:1,000) 
(Beyotime, Shanghai, China). The membranes were 
then exposed to a horseradish peroxidase (HRP)-labeled 
secondary antibody, goat anti-rabbit (1:5,000) or goat anti-
mouse (1:5,000), for 2 h. The color reaction was observed 
with Quantity One 4.6.2 software (Bio Rad, Hercules, CA, 
USA).
Immunohistochemistry
The sections were deparaffinized, rehydrated, and treated 
with antigen-retrieval buffer and diluted hydrogen peroxide. 
The slides were incubated overnight at 4 ℃ with antibodies 
to Sirt1 and Vimentin (CST, Danvers, MA, USA). Then, 
the slides were stained with secondary antibodies for 
60 min. The positivity of immunoreactivity was evaluated 
based on the proportion of positive cells.
Xenograft mouse model of SM
Five-week-old nude mice (half males and half females) were 
randomly divided into two groups and anesthetized using 
sodium pentobarbital (35–40 mg/kg). Approximately 1×106 
sh-circ0006571 and sh-NC H1975 cells were suspended in 
200 µL of serum-free medium. Then, cells were injected 
into the left ventricles of the mice to establish SM animal 
models as previously described (18). After 4–8 weeks, the 
mice underwent luciferase signal scanning (Quantum GX, 
PerkinElmer, Waltham, MA, USA). Mice suspected with 
SM were subjected to further micro-computed tomography 
(CT) scanning (Quantum GX, PerkinElmer, USA) and 
pathological examination. Experiments were performed 
under a project license (No. 2017-154) granted by Animal 
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Ethics Committee of Zhongshan Hospital, in compliance 
with national guidelines for the care and use of animals.
Statistical analyses
Data are expressed as the mean ± standard deviation (mean 
± SD). Differences between two groups were assessed by 
performing Student’s t-test. Differences between more than 
two groups were analyzed with one-way analysis of variance. 
Fisher’s exact test was used to analyze the results of the in 
vivo experiments. Statistical analyses were conducted with 
SPSS software (version 21.0), (SPSS, UK). P<0.05 was 
considered to show statistical significance.
Results
miR-138 inhibited proliferation, migration, and cell-cycle 
in SPC-A1 and H1975 cells in vitro
The quant i f i ca t ion  of  miR-318 by  qRT-PCR in 
human samples showed that miR-138 was significantly 
downregulated in SM tissues compared to lung cancer 
tissues (Figure 1A). Then, the expression of miR-138 in 
lung adenocarcinoma cell lines (H1975, A549, H1395, 
and SPC-A1) and an HBE cell line was investigated. The 
data showed a low expression of miR-138 in H1975 and 
SPC-A1 cells (Figure 1B). However, the expression level 
of miR-138 was slightly increased in A549 cell line. This 
may be due to different cancer cell lines having different 
genetic backgrounds. To study the function of miR-138 in 
lung adenocarcinoma cell lines, miR-138 was overexpressed 
in H1975 and SPC-A1 cells. The proliferation ability of 
H1975 and SPC-A1 cells was found to be significantly 
restrained at 48 and 72 h after transfection with miR-138 
mimic (Figure 1C). Cell cycle analysis indicated that miR-
138 overexpression markedly arrested H1975 and SPC-A1 
cells at the G1/S phase (Figure 1D). Also, the migration 
ability of H1975 and SPC-A1 cells transfected with 
miR-138 mimic was lower than that of the control cells 
(Figure 1E). These results show that miR-138 inhibited the 
proliferation and migration of lung adenocarcinoma cancer 
cells in vitro. 
CircRNA expression profile analysis 
To identify specific circRNAs that might be involved in SM, 
five pairs of lung adenocarcinoma tissues and SM tissues 
pooled from patients were selected. First, the correlation of 
matched tissues was confirmed using box plots, correlation 
plots, Hclust plots, and principal component analysis 
(Figure 2A,B,C,D). Then, the lung adenocarcinoma and SM 
tissue specimens in five pairs were subjected to circRNA 
microarray assay analysis after experimental validation. A 
total of 3,810 circRNAs were found to be differentially 
expressed with a more than two-fold change between lung 
adenocarcinoma tissues and SM tissues (Figure 2E,F). 
Subsequently, FISH assays showed that hsa_circ_0006571 is 
predominately localized in the cytoplasm (Figure 2G). 
miR-138 targeted Sirt1 in lung adenocarcinoma cancer in 
vitro
Consistent with the previous experimental evidence, we 
also identified a negative feedback loop between miR-318 
and Sirt1 (Figure 3A,B,C). After Sirt1 had been established 
as a target of miR-138, western blotting was carried out to 
analyze the expression of proteins involved in tumor cell 
EMT. The results showed that the expression levels of Sirt1 
and Vimentin in H1975 and SPC-A1 cells were clearly 
decreased after transfection with miR-138 mimic, thus 
suggesting that miR-138 is involved in the EMT process in 
tumor cells. Moreover, we performed RIP assay for AGO2 
in tumor cells and investigated the expression level of hsa_
circ_0006571 and miR-138 pulled-down from AGO2-
expressed cells by qRT-PCR analysis. The results indicated 
that association between hsa_circ_0006571 and miR-138 
(Figure 3D). Meanwhile, an RNA pull-down assay detected 
that hsa_circ_0006571 directly interacted with miR-138. 
The results demonstrated that compared with control 
group, miR-138 were significantly enriched in the hsa_
circ_0006571 probe group (Figure 3E). Also, the expression 
of Sirt1 was detected in 10 pairs of samples by qRT-PCR 
and western blotting. Sirt1 was found to be upregulated 
in SM tissues compared with lung adenocarcinoma tissues 
(Figure 3F,G). The results of IHC also validated that Sirt1 
and Vimentin were upregulated in SM tissues (Figure 3H).
Hsa_circ_0006571 directly targeted miR-138 in cells 
To further testify the association between hsa_circ_0006571 
and miR-138, RIP assays were performed using an RIP 
assay Kit (Millipore, Billerica, Massachusetts). Subsequently, 
SPC-A1 cell extracts were incubated with Ago2 (Millipore) 
or IgG (Millipore) according to the specifications. The 
results showed significant enrichment of miR-138 and 
hsa_circ_0006571 with AGO2 antibody (Figure 3D). 
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Figure 1 miR-138 was downregulated in SM and inhibited the proliferation and migration of lung adenocarcinoma cells. (A) Comparison 
of miR-138 expression in SM tissues and lung adenocarcinoma tissues (n=20). (B) Expression of miR-138 in lung adenocarcinoma cells and 
the HBE cell line. (C) Cell Counting Kit-8 assays of H1975 and SPC-A1 cells treated with miR-138 mimic at 48 and 72 h. (D) The effects 
of miR-138 on the cell cycles of H1975 and SPC-A1 cells were determined by flow cytometry. (E) The migration of H1975 and SPC-A1 
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Figure 2 Deregulated circRNAs in SM tissues. (A) Box plot of the sample data, showing symmetric, centralized, homogeneous results. 
(B) Correlation plot showing a strong correlation between the two groups and homogeneity between biological replicates. (C) Hclust plot 
confirming the reliability of the experimental groups. (D) Principal component analysis supporting the rationality of the experimental 
design and the biological homogeneity of repeated samples (red ◇○△ + × lung adenocarcinoma; black ◇○△ + × spinal metastasis). (E) 
Heatmap of differentially expressed circRNAs in SM tissues compared with lung adenocarcinoma tissues. Red denotes a high expression 
and green denotes a low expression, and the horizontal line indicates a P value of 0.05. (F) Volcano plot of differentially expressed circRNAs 
in lung adenocarcinoma tissues compared with SM tissues. The vertical lines represent 2.0-fold upregulation and downregulation, and the 
horizontal line indicates a P value of 0.05 (P1 lung adenocarcinoma, P2 spinal metastasis). (G) RNA FISH assay was used to examine the 
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Figure 3 Sirt1 is a target gene of miR-138 regulated by hsa_circ_0006571. (A) The expression of Sirt1 and the EMT markers E-cadherin 
and Vimentin after transfection with miR-138 mimics in H1975 and SPC-A1 cells. (B) WT and MUT sequences designed for Sirt1 
according to the binding site for miR-138. (C) Luciferase reporter assays confirmed the binding of miR-138 with Sirt1. (D) RIP assay was 
performed using anti-Ago2 in SPC-A1 cells, and the coprecipitated miR-138 was subjected to qRT-PCR for hsa_circ_0006571. (E) RNA 
pull-down assay confirmed hsa_circ_0006571 binding to miR-138. (F) A high expression of Sirt1 was observed in SM tissues compared 
with that in lung adenocarcinoma tissues, as determined by Western blotting. (G) Sirt1 expression in SM tissues was analyzed by qRT-PCR 
(n=20). (H) Expression levels of Sirt1 and Vimentin in SM tissues and adjacent normal tissues were examined using IHC (200×). *, P<0.05; 
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Subsequently, the RNA pull-down assay confirmed the 
interaction between hsa_circ_0006571 and miR-138. The 
results indicated a higher level of miR-138 in the hsa_
circ_0006571 pulled-down pellet than in the negative 
control (Figure 3E). Both the RIP and RNA pull-down 
assays confirmed the interaction between hsa_circ_0006571 
and miR-138 via Ago2-containing complexes.
Downregulation of Sirt1 inhibited the proliferation, 
invasion, and migration abilities of cancer cells
H1975 and SPC-A1 cells were transfected with an si-Sirt1 
RNA interference sequence to inhibit Sirt1 expression. 
At the molecular level, western blotting showed that 
Sirt1 expression was clearly decreased by the interference 
sequence, and the downregulation of Sirt1 inhibited H1975 
and SPC-A1 cell proliferation (Figure 4A,B). The cell 
cycle data showed that Sirt1 knockdown arrested H1975 
and SPC-A1 at the G1/S phase (Figure 4C). With the 
downregulation of Sirt1 protein expression, the expression 
levels of the EMT markers Vimentin, Snail, and ZEB1 
decreased, whereas those of E-cadherin and ZO-1 increased 
(Figure 4D,E). Moreover, the downregulation of Sirt1 
decreased the migration ability of H1975 and SPC-A1 cells 
(Figure 4F). In conclusion, these findings suggested that 
Sirt1 exerts an oncogenic effect in lung cancer by regulating 
the EMT process. 
hsa_circ_0006571 regulates the proliferation and 
migration of lung adenocarcinoma cells via the miR-138-
Sirt1 axis
To explore the effect of hsa_circ_0006571 on SM, qRT-
PCR was performed on 10 pairs of SM tissues to verify the 
circRNA array data. As miR-138 was downregulated in SM 
tissues, we speculated that miR-138 may be suppressed in 
SM by the upregulation of hsa_circ_0006571. Consistent 
with that of the miR-138 target Sirt1, the expression of hsa_
circ_0006571 was found to be upregulated in SM tissues 
compared with lung adenocarcinoma tissues (Figure 5A).
After confirming that hsa_circ_0006571 binds to miR-
138 and is positively correlated with Sirt1 expression, we 
considered that hsa_circ_0006571 may have an oncogenic 
role in lung adenocarcinoma cells. Hsa_circ_0006571 
was knocked down via a specific siRNA targeting the 
splice junction of hsa_circ_0006571 (Figure 5B,C). The 
proliferation ability of H1975 and SPC-A1 cells was 
significantly decreased by si-hsa_circ_0006571 (Figure 5D).
However, no apparent increase in miR-138 levels was 
observed as a result of hsa_circ_0006571 knockdown. 
Rescue experiments were conducted to identify whether 
hsa_circ_0006571 regulates H1975 and SPC-A1 cell 
proliferation and Sirt1 expression through inhibiting miR-
138. The decreases in the proliferation and migration of 
H1975 and SPC-A1 cells resulting from hsa_circ_0006571 
knockdown was rescued by the addition of miR-138 
inhibitor (Figure 5E,F,G). Moreover, the repression of 
Sirt1 by hsa_circ_0006571 was also rescued after miR-138 
was inhibited (Figure 5H). These results suggest that hsa_
circ_0006571 regulates the proliferation and migration of 
lung adenocarcinoma cells via the miR-138-Sirt1 axis.
hsa_circ_0006571 inhibited cell apoptosis and promotes 
EMT in H1975 and SPCA-1 cells
To further test the effects of hsa_circ_0006571 on H1975 
and SPCA-1 cells, siRNAs were used to downregulate 
the expression of hsa_circ_0006571. Flow cytometry was 
performed to detect cell apoptosis, and downregulation 
of hsa_circ_0006571 was found to promote cell apoptosis, 
which was consistent with the results of western blot 
(Figure 6A,B). Further, cells treated with siRNA exhibited 
morphological changes. Cells lost their elongated 
fibroblast-like shape and acquired an epithelial cobblestone-
like morphology. After transfection, cellular protrusions 
disappeared when compared to control group (Figure 6C). 
These modifications were observed in both H1975 and 
SPC-A1 cells and indicated that the downregulation of hsa_
circ_0006571 inhibited the EMT process.
Knockdown of hsa_circ_0006571 suppressed tumor growth 
in vivo
In vitro, hsa_circ_0006571 knockdown was observed 
to suppress the viability of H1975 and SPC-A1 cells. 
Therefore, we postulated that hsa_circ_0006571 may 
play the same role in vivo. H1975 cells with stable hsa_
circ_0006571 knockdown (sh-hsa_circ_0006571-H1975) 
or cells infected with control vector (sh-NC-H1975) were 
injected into the left ventricle of nude mice.
Consistent with the in vitro results, knockdown of hsa_
circ_0006571 suppressed SM in vivo. Micro CT, Spect-
CT, and images of luciferase signal scans showed SM in 4 
of the 10 nude mice in the si-H1975 group, and the lesion 
of each mouse involved multiple vertebral segments. In 
the sh-NC-H1975 group, 1 of the 10 nude mice exhibited 
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Figure 4 Sirt1 promotes the proliferation and migration of lung adenocarcinoma cells. (A) Knockdown efficiency of Sirt1 in H1975 and 
SPC-A1 cells, as determined by western blot. (B) Knockdown of Sirt1 suppressed the proliferation in H1975 and SPC-A1 cells, as detected 
with CCK-8 assays. (C) The effect of Sirt1 knockdown on the cell cycle in H1975 and SPC-A1 cells, as analyzed by flow cytometry. (D,E) 
The expression of EMT-related proteins in H1975 and SPC-A1 cells, as determined by Western blot after Sirt1 knockdown. (F) Knockdown 
of Sirt1 suppressed the migration ability of H1975 and SPC-A1 cells, as determined by Transwell assays (200×). *, P<0.05; **, P<0.01. Sirt1, 
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Figure 5 Hsa_circ_0006571 regulates the proliferation and migration of lung adenocarcinoma cells via the miR-138-Sirt1 axis. (A) The 
expression of hsa_circ_0006571 in SM tissues and lung adenocarcinoma tissues (n=20). (B,C) Knockdown efficacy of hsa_circ_0006571 in 
H1975 and SPC-A1 cells, as determined by qRT-PCR and Western blotting, respectively. (D) The effects of hsa_circ_0006571 knockdown 
on H1975 and SPC-A1 cells, as determined by CCK-8 assays. (E,F,G) miR-138 inhibitor treatment rescued the si-hsa_circ_0006571-
induced decrease in the migration and proliferation of both H1975 and SPC-A1 cells (200×). (H) Decreases in Sirt1 induced by si-hsa_
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Figure 6 Hsa_circ_0006571 inhibits cell apoptosis and blocks EMT morphological changes. (A) Annexin V-APC assay was performed to 
analyze apoptosis of H1975 and SPC-A1 cells after siRNA transfection. (B) The expression levels of cleaved caspase-3 and Bax in transfected 
H1975 and SPC-A1 cells were determined by Western blotting. (C) After siRNA transfection, H1975 and SPC-A1 showed fewer 





















2423Translational Lung Cancer Research, Vol 9, No 6 December 2020
© Translational Lung Cancer Research. All rights reserved.   Transl Lung Cancer Res 2020;9(6):2411-2427 | http://dx.doi.org/10.21037/tlcr-20-1250
SM (Figure 7 and Figure 8A). IHC analysis also validated 
the downregulation of Sirt1 and Vimentin in sh-hsa_
circ_0006571-H1975 samples in vivo (Figure 8B).
The differences in the occurrence of SM between the sh-
hsa_circ_0006571-H1975 and sh-NC-H1975 groups were 
not statistically significant. All SM samples were examined 
through pathological examination, including hematoxylin-
eosin staining and IHC. In conclusion, hsa_circ_0006571 
may act as a novel therapeutic target for SM of lung 
adenocarcinoma tumors via the miR-138-Sirt1 axis.
Discussion
MiRNAs are important epigenetic regulators of gene 
expression which are involved in cancer metastasis. MiRNAs 
participate in multi-level processes and play a key role in the 
progression of tumors (19). Here, we confirmed that miR-
138 was downregulated in SM samples and inhibited the 
proliferation and migration abilities of SPC-A1 and H1975 
cells. This is in agreement with the findings of previous 
research that demonstrated the anti-oncogenic function of 
miR-138 in multiple cancers (20). 
Generally, miRNAs bind the 3'-UTRs of messenger 
RNAs (mRNAs), leading to the degeneration of mRNAs 
or translational blockage (21). The current study validated 
Sirt1 as a target of miR-138 and verified its role in lung 
adenocarcinoma. Sirt1 has important involvement in cell 
proliferation and apoptosis, especially in tumorigenesis 
and cancer metastasis (22,23). Sirt1 could interact with p53 
and result in deacetylation of Lys 382 at the C-terminal 
of p53. Therefore, a series of tumor suppressor were not 
activated by p53, such as transcription activation (24). In 
epigenetics, Sirt1 also could inhibit the tumor suppressor 
functions and affect the activities of DNA repair-related 
protein (25,26). Our in vitro experiments demonstrated that 
miR-138 overexpression downregulated Sirt1 expression 
by facilitating the degradation of Sirt1. In agreement with 
previous findings, our functional experiments revealed 
that silencing of Sirt1 decreased cell proliferation, 
migration and inhibited the EMT process. This resulted 
in the upregulation of E-cadherin and ZO-1, and the 
downregulation of Vimentin, snail, and ZEB1, which are 
involved in EMT (27-29).
CircRNAs are increasingly being reported to be 
important regulators in various physiological and 
pathological cancer processes. Dysregulation of circRNA 
expression contributes to malignant behaviors in cancers, 
including lung cancer (30), hepatocellular cancer (31), and 
breast cancer (32). In summary, dysregulated circRNA 
expression is clearly associated with the progression and 
prognosis of cancer, and is always directly involved in 
malignant behaviors, including proliferation, metastasis, 
and invasion (33). Uncovering the relationship between 
circRNA and spine metastasis of lung cancer is crucial. 
Considering the downregulation of miR-138 in SM 
tissues，and the and role of circRNAs, we hypothesized 
that the low expression level of miR-138 may partly be 
attributed to the abundance of circRNAs. In this study, 
we used the SBC human ceRNA array V1.0 to identify a 
circRNA termed hsa_circ_0006571 and validate its tumor 
oncogenic function in lung cancer metastasis. H1975 and 
SPC-A1 cells transfected with si-hsa-circ_000657 were 
observed to display evident morphological changes, from 
an elongated morphology with cellular protrusions to an 
epithelial cobblestone-like morphology, which indicated 
the inhibition of the EMT process. This suggested that si-
hsa-circ_000657 could inhibit cells to gain a fibroblast-
like mesenchymal morphology, one of the main features 
acquired by cells undergoing EMT, and could then reduce 
spinal metastatic potential of lung cancers. Therefore, hsa_
circ_0006571 may serve as a potential biomarker for lung 
adenocarcinoma diagnosis and prognosis.
CircRNAs often act as miRNA sponges. To explore the 
functional mechanism of circRNAs and miRNA-138, we 
used circRNA microarray to determine potential circRNAs, 
and hsa_circ_0006571 was eventually identified. Through 
luciferase reporter assays and RNA FISH assays, the 
association between hsa_circ_0006571 and miR-138 in 
lung adenocarcinoma cells was identified. Meanwhile, RIP 
and RNA pull-down showed that hsa_circ_0006571 served 
as a miRNA sponge for miR-138 in H1975 and SPC-A1 
cells. It is worth noting that the high expression level of 
hsa_circ_0006571 was positively correlated with the high 
expression of Sirt1, which indicated that hsa_circ_0006571 
might regulate Sirt1 expression by sponging miR-138. The 
consequent declines in the protein level of Sirt1, and in cell 
viability and migration were rescued by inhibiting miR-138, 
which was consistent with the findings of previous studies. 
This result indicated that hsa_circ_0006571 regulates 
Sirt1 expression via miR-138. However, in our in vivo 
experiments, no statistically significant differences in SM 
were observed between the sh-hsa_circ_0006571-H1975 
and sh-NC-H1975 groups. This lack of significance might 
have resulted from the limited sample size or because 
inoculated cells did not undergo bone tropism induction, 
as described in a previous study (18); however, the rates of 
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Figure 7 Knockdown of hsa_circ_0006571 suppressed SM in vivo. (A,B) Representative micro-computed tomography and X-ray scans 
showing local osteolytic lesions (arrow) in the affected vertebrae of tumorigenic nude mice. (C) After left ventricular injection, the tumor 
cells were distributed all over the body, according to images of luciferase signals. (D) Images of luciferase signals in nude mice inoculated in 
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Figure 8 Knockdown of hsa_circ_0006571 suppressed SM in vivo. (A) Spect-computed tomography for SM. (B) Hematoxylin-eosin staining 
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SM and the involvement of pathological vertebral segments 
were increased in the sh-NC-H1975 group compared 
to the sh-hsa_circ_0006571-H1975 group. Additionally, 
we detected the correlations among hsa_circ_0006571, 
miR-138, and Sirt1 in cancer tissues, and the underlying 
mechanism, by using techniques including western blotting 
and luciferase assay. In future studies, we may investigate 
the mechanism of SM of lung cancer using cancer cells 
overexpressing hsa_circ_0006571 combined with bone 
tropism induction. Overall, our experiments revealed that 
hsa_circ_0006571 regulates the proliferation and migration 
of lung adenocarcinoma cells via the miR-138-Sirt1 axis.
In conclusion, this study provides initial evidence that 
hsa_circ_0006571 regulates the migration and proliferation 
of lung adenocarcinoma cells via the miR-138-Sirt1 axis. 
Our in vivo experiment also showed that hsa_circ_0006571 
knockdown can suppress the development of SM. This 
study sheds light on a novel mechanism potentially involved 
in SM of lung adenocarcinoma.
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Table S2 List of primers of the genes and the probe sequence





Table S1 Sequence of all siRNAs
siRNA Sequence (5’-3’)
si-circ_0006571 TCAGTGGAAAGAGTGGAAC
si-sirt1 CTGGAGCTGGGGTGTCTGT
